Adorable Tasmanian Devils Could Help Fight Superbugs

Special compounds in their milk work like antibiotics.

<a href="http://www.istockphoto.com/photo/watchful-devil-gm152130740-14397746?st=_p_tasmanian%20devil">Redzaal</a>/iStock

Facts matter: Sign up for the free Mother Jones Daily newsletter. Support our nonprofit reporting. Subscribe to our print magazine.


Even though they’re cute, Tasmanian devils really do exhibit somewhat diabolical behavior. Turns out, these kitty-sized marsupials might just be fierce enough to stare down one of the nastiest health crises facing humanity: the rise of antibiotic-resistant pathogens, which kill 700,000 people per year globally and about 23,000 people in the United States.

No, ERs and doctor’s offices won’t keep a pet devil around to bare its fangs at samples of hard-to-treat E. coli. What physicians may someday do is treat patients with antibiotics derived from compounds found in devil milk. Vice‘s Kaleigh Rogers puts it like this:

Tiny devil babies are born after just 30 days of gestation, and their immune systems are not fully developed. They continue to grow from the safety of their mother’s pouch, but that doesn’t protect them from potentially dangerous bacteria, viruses, and fungi. Instead, the babies build up immunity partly through drinking their mother’s milk, which is full of cathelicidins—small compounds of amino acids that work like natural antibiotics.

For a recently published paper, scientists at the University of Sydney isolated the cathelicidins and sicced them on a range of resistant bacteria—and two of them worked. They also found that like many existing antibiotics, cathelicidins are toxic to humans in high amounts, but safe at medicinal doses.

The findings, while promising, don’t point to a solution for the resistance threat. For one thing, the compounds need to be tested further and approved by regulatory agencies, and pharmaceutical companies need to figure out how to produce them at scale at a viable cost. Ever tried to milk a Tasmanian devil? Actually, the challenge will be figuring out to economically synthesize large amounts of those cathelicidins.

More broadly, we desperately need new drugs to treat resistant pathogens; but microbes evolve and swap genes rapidly, and they’ll eventually outfox even these Tasmanian devil compounds if we continue overusing antibiotics in human medicine and on farms

THE END...

of our fiscal year is Thursday, June 30, and we have a much larger fundraising gap than we can easily manage with only days left to go.

Right now is no time to come up short: If you value the hard-hitting, democracy-protecting, justice-advancing journalism you get from Mother Jones, please help us keep charging as hard as we possibly can with a much-needed and much-appreciated donation today.

payment methods

THE END...

of our fiscal year is Thursday, June 30, and we have a much larger fundraising gap than we can easily manage with only days left to go.

Right now is no time to come up short: If you value the hard-hitting, democracy-protecting, justice-advancing journalism you get from Mother Jones, please help us keep charging as hard as we possibly can with a much-needed and much-appreciated donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate